Immunotherapy

https://www.futuremedicine.com/journal/imt

ISSN (print): 1750-743X | ISSN (online): 1750-7448

Frequency: 18 issues per year

Impact Factor: 2.8 (2022)

The field of immunotherapy is moving forward at an unprecedented rate, and a range of therapeutic approaches are now used in clinical practice, often with outstanding success. Cancer immunotherapies are coming of age and have the potential to produce long-lasting remission, often with fewer side effects and reduced drug resistance compared with conventional therapies. Recently the FDA has approved immunotherapies for melanoma and lung cancer, and clinical trials are yielding positive results for a range of cancer types, reflecting the promising new role for immunotherapy in cancer treatment. Immunotherapies are also being applied in a variety of other disease areas, including allergy, rheumatoid disease, autoimmunity and transplantation, as well as in many infections, such as HIV and hepatitis.

Many aspects of the immune system and mechanisms of immunomodulatory therapies remain to be elucidated in order to exploit fully the emerging opportunities. Those involved in the research and clinical applications of immunotherapy are challenged by the huge and intricate volumes of knowledge arising from this fast-evolving field. The journal Immunotherapy offers the scientific community an interdisciplinary forum, providing them with information on the most recent advances of various aspects of immunotherapies, in a concise format to aid navigation of this complex field.

Articles published in Immunotherapy include key areas such as:

Cancer immunotherapy, including checkpoint blockade, cancer vaccines, adoptive T cell therapy, monoclonal antibodies and cytokines
Combined chemo/radio immunotherapy in cancer treatment
Biomarkers for personalized cancer immunotherapy
Allergen immunotherapy, including sublingual, subcutaneous and oral immunotherapy
Restorative immunotherapy for HIV and other immunocompromised patients
Suppressive immunotherapy for autoimmunity diseases and transplantation
Basic science of immunotherapeutic approaches
Drug–immune system interactions
Drug delivery systems, drug combinations and drug–drug interactions
Summaries evaluating newly approved immunotherapeutic agents
Newly identified immune targets of drugs
Results of recent findings and clinical trials relevant to the field of immunotherapy
Post marketing research, including adverse events, drug safety, pharmacoeconomics, cost–benefit issues, real-world evidence and outcomes research

Immunotherapy delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal’s Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.